ALPS ETF TR - ALERIAN MLP (AMLP)

CUSIP: 00162Q452

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / ALERIAN MLP
Total 13F shares
104,528,488
Share change
+2,677,788
Total reported value
$4,906,139,853
Put/Call ratio
114%
Price per share
$46.93
Number of holders
722
Value change
+$124,121,246
Number of buys
400
Number of sells
249

Security key

00162Q452

Report period

Q3 2025

Institutions

722

Top holders

10

Ownership snapshot

Top shareholders of AMLP - ALPS ETF TR - ALERIAN MLP (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
13D/G signal
Evidence rows
0
Latest as of
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
722
Shares
104,528,488
Rows loaded
725
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
729
Q3 2025 holders
722
Holder diff
-7
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .